Sequenom, Inc. Announces Participation At The 2014 Wedbush Securities Life Sciences Management Access Conference

  Sequenom, Inc. Announces Participation At The 2014 Wedbush Securities Life                     Sciences Management Access Conference  PR Newswire  SAN DIEGO, Aug. 5, 2014  SAN DIEGO, Aug. 5, 2014 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the 2014 Wedbush Securities Life Sciences Management Access Conference at Le Parker Meridien in New York, NY on August 12-13, 2014.  William Welch, President and Chief Operating Officer, will present on Tuesday, August 12, beginning at 4:15 p.m. ET to provide an overview of and update on the Company. The presentation is expected to last approximately 30 minutes and will be webcast live through the "Invest" section of the Sequenom Web site at www.sequenom.com. An audio replay will be available for 30 days following the initial broadcast.  About Sequenom Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving health care through revolutionary genomic and genetic analysis solutions. Sequenom develops innovative technologies, products, and diagnostic tests that target and serve molecular diagnostic markets. Web site: www.sequenom.com  SEQUENOM logo.  Logo - http://photos.prnewswire.com/prnh/20040415/SQNMLOGO  SOURCE Sequenom, Inc.  Website: http://www.sequenom.com Contact: Carolyn Beaver, Chief Financial Officer, Sequenom, Inc., 858-202-9028, investorrelations@sequenom.com or Rachel Kennedy, Media Contact, Chandler Chicco Agency, 858-449-9575, rkennedy@chandlerchiccocompanies.com  
Press spacebar to pause and continue. Press esc to stop.